Depot-medroxy Progesterone Acetate Injectable Contraceptives in Lactating Women 1st Week Versus 6 Week Postpartum Initiation
NCT ID: NCT06100783
Last Updated: 2023-10-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
120 participants
INTERVENTIONAL
2021-01-01
2023-10-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This study is open labeled -randomized clinical trial was used. It was conducted at woman's health hospital, Assuit University. This study applied on 120 lactating women, who divided into two equal group I (who used DMPA injectable in the 1st week postpartum) and group II (who used DMPA injectable in the 6th week postpartum). Each group included 60 lactating women). Follow up was carried out after 3 months from the first dose to determine the changes in the studied women's menstrual period, weight, breast feedings…etc.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Timing of Postpartum Depot Medroxyprogesterone Acetate Administration on Breastfeeding, Contraceptive Continuation, and Depression
NCT01463202
Measuring Lactation Initiation After Early Postpartum Injectable Progestin (DMPA) Use Among Women in Dhanusha District of Nepal: A Pilot Study
NCT06816901
Breastfeeding and Oral Contraceptives: a Randomized, Controlled Trial
NCT01465022
Progestin-Only Pill Use and Breastfeeding Study
NCT04965116
Acceptability & Tolerance of Immediate Versus Delayed Postpartum Contraceptive Implant
NCT03353012
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Women using DMPA after 6 weeks postpartum
Depot-medroxy Progesterone Acetate Injectable Contraceptives
Depot-medroxy progesterone acetate injectable contraceptives
Women using DMPA after 1 week postpartum
Depot-medroxy Progesterone Acetate Injectable Contraceptives
Depot-medroxy progesterone acetate injectable contraceptives
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Depot-medroxy Progesterone Acetate Injectable Contraceptives
Depot-medroxy progesterone acetate injectable contraceptives
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
20 Years
40 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assiut University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Boshra Hussien
Specialist of Reproductive Health
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Boshra Hussien Ahmed
Asyut, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
boshahussien2021
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.